Patent14 Oct 2026, 06:10 pm
Godavari Biorefineries gets US Patent for Cancer Treatment
AI Summary
Godavari Biorefineries Ltd has announced the approval of its United States patent application for "5-Hydroxy-1,4-Naphthalenedione for use in the treatment of cancer." This patent protects a novel class of compounds that effectively inhibit cancer and cancer stem cells, showing significant potential against various cancer types, including breast and prostate. The granted patent provides exclusive rights to the company in the US for making, using, offering for sale, or selling the invention for a specified term.
Key Highlights
- US patent granted for cancer treatment compound.
- Patent protects novel class of anti-cancer compounds.
- Shows potential against breast and prostate cancers.
- Secures exclusive rights in the United States.
Price Impact
More from GODAVARIB